Insights Into Colgate-Palmolive (CL) Q3: Wall Street Projections for Key Metrics

Core Insights - Colgate-Palmolive (CL) is expected to report quarterly earnings of $0.88 per share, a 2.3% increase year-over-year, with revenues projected at $5.01 billion, reflecting a 1.9% increase [1] - The consensus EPS estimate has remained stable over the past 30 days, indicating analysts' reassessment of their initial forecasts [1] - Analysts emphasize the importance of earnings estimate revisions in predicting investor reactions and stock performance [1] Revenue Forecasts - Analysts predict 'Net Sales- Pet Nutrition' will reach $1.10 billion, a 3.5% increase from the prior year [2] - 'Net Sales- Total Oral, Personal and Home Care' is expected to be $3.90 billion, indicating a 1.2% year-over-year increase [2] - 'Net Sales- Oral, Personal and Home Care- North America' is forecasted at $999.71 million, reflecting a 1% increase from the previous year [2] Regional Sales Estimates - 'Net Sales- Oral, Personal and Home Care- Latin America' is expected to be $1.19 billion, showing a slight decline of 0.3% year-over-year [3] - 'Net Sales- Oral, Personal and Home Care- Africa/Eurasia' is projected at $266.72 million, a 0.3% increase from the prior year [3] - 'Net Sales- Oral, Personal and Home Care- Europe' is estimated at $746.52 million, reflecting a 3% increase year-over-year [3] - 'Net Sales- Oral, Personal and Home Care- Asia Pacific' is expected to reach $700.99 million, indicating a 2.8% increase from the previous year [3] Operating Profit Estimates - 'Operating profit- Total Oral, Personal and Home Care' is projected to be $1.07 billion, up from $1.02 billion reported in the same quarter last year [3] - 'Operating profit- Pet Nutrition' is estimated at $217.20 million, compared to $201 million in the prior year [4] - 'Operating profit- Oral, Personal and Home Care- North America' is forecasted at $227.01 million, slightly down from $231 million reported last year [4] - 'Operating profit- Oral, Personal and Home Care- Latin America' is expected to reach $405.27 million, up from $372 million in the previous year [4] - 'Operating profit- Oral, Personal and Home Care- Africa/Eurasia' is estimated at $68.01 million, compared to $66 million reported last year [4] Stock Performance - Over the past month, Colgate-Palmolive shares have declined by 3.8%, while the Zacks S&P 500 composite has increased by 2.8% [5] - The company holds a Zacks Rank 3 (Hold), suggesting it will likely perform in line with the overall market in the near term [5]